BDBM50169699 (2-Benzyl-1H-benzoimidazol-5-yl)-(1,3,8a,9-tetraaza-fluoren-4-yl)-amine::CHEMBL361322

SMILES c1ccc(Cc2nc3ccc(Nc4ncnc5nn6ccccc6c45)cc3[nH]2)cc1

InChI Key InChIKey=IVNIGGUBKAEFHI-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50169699   

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50169699BDBM50169699((2-Benzyl-1H-benzoimidazol-5-yl)-(1,3,8a,9-tetraaz...)
Affinity DataIC50: 1.58E+3nMpH: 7.5Assay Description:Inhibitory concentration against ErbB-2 protein tyrosine kinase by using [gamma-33P]-ATP as radioligand in pH 7.5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Glaxosmithkline

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50169699BDBM50169699((2-Benzyl-1H-benzoimidazol-5-yl)-(1,3,8a,9-tetraaz...)
Affinity DataIC50: 5.01E+3nMpH: 7.5Assay Description:Inhibitory concentration against EGFR by using [gamma-33P]-ATP as radioligand in pH 7.5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed